Leptin, an adipocyte-secreted hormone, regulates energy homeostasis as well as reproductive, neuroendocrine, immune and metabolic functions. Subjects with decreased amounts of fat in their adipose tissue, i.e., lipoatrophy, have low leptin levels. In the context of open-label, uncontrolled studies leptin administration, in physiological replacement doses, has been shown to have metabolically salutary effects in the rare patients with the syndrome of congenital lipodystrophy accompanied by leptin deficiency. Much more patients with lipodystrophy suffer from lipodystrophy and the metabolic syndrome associated with the use of highly active antiretroviral therapy. In this so called highly active antiretroviral therapy (HAART)-associated lipodystrophy and metabolic syndrome, patients demonstrate fat maldistribution with dyslipidemia, insulin resistance, and other metabolic complications. Leptin administration has been shown to decrease central fat mass and to improve fasting insulin/glucose levels and insulin sensitivity in human immunodeficiency virus-infected hypoleptinemic patients with HAART induced lipodystrophy and the metabolic syndrome. By contrast, the results of leptin treatment in leptin replete or hyperleptinemic obese individuals with glucose intolerance and diabetes mellitus have been minimal or null, presumably due to leptin tolerance or resistance that impairs leptin action. In this review, we present the emerging clinical applications and potential therapeutic uses of leptin in humans with lipodystrophy and the metabolic syndrome.

Citations

Citations to this article as recorded by  

• Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery
  Michail Kokkorakis, Angeliki Katsarou, Niki Katsiki, Christos S. Mantzoros
  Metabolism.2023; 148: 155689.     CrossRef
• The common pathophysiologic threads between Asian Indian diabetic’s ‘Thin Fat Phenotype’ and partial lipodystrophy: the peripheral adipose tissue transcriptomic evidences
  Aditya Saxena, Pradeep Tiwari, Nitin Wahi, Anshul Kumar, Sandeep Kumar Mathur
  Adipocyte.2020; 9(1): 253.     CrossRef
• The effect of underweight on female and male reproduction
  Chrysoula Boutari, Panagiotis D. Pappas, Gesthimani Mintziori, Meletios P. Nigdelis, Loukas Athanasiadis, Dimitrios G. Goulis, Christos S. Mantzoros
  Metabolism.2020; 107: 154229.     CrossRef
• Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy
  Baris Akinci, Huseyin Onay, Tevfik Demir, Şenay Savas-Erdeve, Ramazan Gen, Ilgin Yildirim Simsir, Fatma Ela Keskin, Mehmet Sercan Erturk, Ayse Kubat Uzum, Guzin Fidan Yaylali, Nilufer Kutbay Ozdemir, Tahir Atik, Samim Ozen, Banu Sarer Yurekli, Tugce Apayd
  Metabolism.2017; 72: 109.     CrossRef
• CURRENT STATE OF THE PROBLEM OF OVERWEIGHT AND OBESITY IN WOMEN
  L. V. Tkachenko, N. I. Sviridova, T. V. Skladanovskaya
  Journal of Volgograd State Medical University.2017; 14(4): 3.     CrossRef
• Leptin and Hormones
  Georgios A. Triantafyllou, Stavroula A. Paschou, Christos S. Mantzoros
  Endocrinology and Metabolism Clinics of North America.2016; 45(3): 633.     CrossRef
• An allosteric antibody to the leptin receptor reduces body weight and reverses the diabetic phenotype in the Lepob/Lepob mouse
  Vinay Bhaskar, Ira D. Goldfine, Resi Gerstner, Kristen Michelson, Catarina Tran, Genevieve Nonet, David Bohmann, Elizabeth Pongo, Jingsong Zhao, Arnold H. Horwitz, Toshihiko Takeuchi, Mark White, John A. Corbin
  Obesity.2016; 24(8): 1687.     CrossRef
• Lipodystrophic Diabetes Mellitus: a Lesson for Other Forms of Diabetes?
  Romina Ficarella, Luigi Laviola, Francesco Giorgino
  Current Diabetes Reports.2015;[Epub]     CrossRef
• Aldehyde Dehydrogenase 1A1: Friend or Foe to Female Metabolism?
  Jennifer Petrosino, David DiSilvestro, Ouliana Ziouzenkova
  Nutrients.2014; 6(3): 950.     CrossRef
• Comparative endocrinology of leptin: Assessing function in a phylogenetic context
  Richard L. Londraville, Yazmin Macotela, Robert J. Duff, Marietta R. Easterling, Qin Liu, Erica J. Crespi
  General and Comparative Endocrinology.2014; 203: 146.     CrossRef
• Central obesity and altered peripheral adipose tissue gene expression characterize the NAFLD patient with insulin resistance: Role of nutrition and insulin challenge
  J.A. Paniagua, J.M. Escandell-Morales, D. Gil-Contreras, F.J. Berral de la Rosa, M. Romero-Jimenez, A. Gómez-Urbano, A. Sanchez-Lopez, E. Bellido, A. Poyato, B. Calatayud, A.J. Vidal-Puig
  Nutrition.2014; 30(2): 177.     CrossRef
• The complex interaction between obesity, metabolic syndrome and reproductive axis: A narrative review
  Konstantinos Michalakis, Gesthimani Mintziori, Athina Kaprara, Basil C. Tarlatzis, Dimitrios G. Goulis
  Metabolism.2013; 62(4): 457.     CrossRef
• Dietary supplementation with long-chain monounsaturated fatty acids attenuates obesity-related metabolic dysfunction and increases expression of PPAR gamma in adipose tissue in type 2 diabetic KK-Ay mice
  Zhi-Hong Yang, Hiroko Miyahara, Yusuke Iwasaki, Jiro Takeo, Masashi Katayama
  Nutrition & Metabolism.2013; 10(1): 16.     CrossRef
• Embryo-transfer of the F2 postnatal calorie restricted female rat offspring into a control intra-uterine environment normalizes the metabolic phenotype
  Meena Garg, Manikkavasagar Thamotharan, Yun Dai, Paul W.N. Lee, Sherin U. Devaskar
  Metabolism.2013; 62(3): 432.     CrossRef
• Obesity in the ageing man
  K. Michalakis, D.G. Goulis, A. Vazaiou, G. Mintziori, A. Polymeris, A. Abrahamian-Michalakis
  Metabolism.2013; 62(10): 1341.     CrossRef
• Acylated and Desacylated Ghrelin, Preptin, Leptin, and Nesfatin-1 Peptide Changes Related to the Body Mass Index
  Yusuf Ozkan, Esra Suay Timurkan, Suleyman Aydin, İbrahim Sahin, Mustafa Timurkan, Cihan Citil, Mehmet Kalayci, Musa Yilmaz, Aziz Aksoy, Zekiye Catak
  International Journal of Endocrinology.2013; 2013: 1.     CrossRef
• Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome
  Maria Dalamaga, Konstantinos Karmaniolas, John Chamberland, Athina Nikolaidou, Antigoni Lekka, Amalia Dionyssiou-Asteriou, Christos S. Mantzoros
  Metabolism.2013; 62(12): 1830.     CrossRef
• Metabolische Korrektur mit Leptin
  Konstanze Miehle, Michael Stumvoll, Mathias Fasshauer, Wieland Kiess, Thomas Kapellen
  Info Diabetologie.2012; 6(5): 37.     CrossRef